9 results match your criteria: "Blokhin Oncological Research Center[Affiliation]"
Colloids Surf B Biointerfaces
September 2014
Department of Pharmaceutics and Biopharmacy, Philipps University, Ketzerbach 63, D-35037 Marburg, Germany.
In our study we examined thermosensitive liposomal formulations (TL) from the perspective to minimize the general toxicity drawbacks of chemotherapy. The TL become active in response to local hyperthermia (LH), and remain inactive at physiological conditions. Here, we formulated novel doxorubicin loaded thermoliposomes (Dox-TL) with optimized characteristics and tested their biological activity in vitro.
View Article and Find Full Text PDFDokl Biol Sci
May 2009
Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Moscow 115478, Russia.
Dokl Biol Sci
March 2006
Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Moscow, Russia.
Dokl Biol Sci
December 2005
Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Kashirskoe sh. 24, Moscow, 115478 Russia.
Dokl Biol Sci
December 2005
Research Institute of Experimental Diagnostics and Therapy of Tumors, Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Kashirskoe sh 24, Moscow, 115478 Russia.
Bull Exp Biol Med
April 2005
Institute of Carcinogenesis, N. N. Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Russia.
Olivomycin (DNA-binding antibiotic) in nanomolar concentrations induces apoptosis of human tumor cells and inhibits p53-dependent transcription of the reporter gene (basal and induced by antitumor drugs). Olivomycin aglycon induces no cytotoxicity and does not block transcription.
View Article and Find Full Text PDFDokl Biol Sci
September 2005
Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Kashirskoe sh. 24, Moscow, 115478, Russia.
Dokl Biol Sci
April 2001
Blokhin Oncological Research Center, Russian Academy of Medical Sciences, Moscow, Russia.
Zh Mikrobiol Epidemiol Immunobiol
September 2001
Bioengineering Center, Blokhin Oncological Research Center, Mechnikov Research Institute for Vaccines and Sera, Moscow, Russia.
51 bacterial strains were studied with a view to find out anticandidial activity; of these, 15 strains were found to have activity, more on less expressed with respect to fungi of the genus Candida. In most cases the anticandidial activity of an antagonist strain was manifested to a similar degree against several Candida strains. The preliminary analysis of antifungal substances produced by microbial strains makes it possible to suggest their antibiotic nature.
View Article and Find Full Text PDF